Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study
Related Posts
Hughes JW, Theurer J, Vukadinovic M, Rogers AJ, Somani S, Kang G, Ghazizadeh Z, O'Sullivan JW, Jain SS, Gomes B, Salerno M, Ashley E, Zou[...]
Abbott A, Swertfager K, Bloom S, Jackson NJ, Goldman J. Pediatric Fracture Epidemiology in an Orthopaedic Urgent Care Setting. J Pediatr Soc North Am. 2025[...]
Erlandson KM, Umbleja T, Ribaudo HJ, Lu MT, Taron J, Diggs MR, Douglas PS, Fitch KV, Fichtenbaum CJ, Zanni MV, Aberg JA, Rodriguez-Barradas MC, Breaux[...]